Comparison of ridaforolimus-eluting and zotarolimus-eluting coronary stents: 5-Year outcomes from the BIONICS and NIREUS trials

Back

ESC Professional Premium Access

Comparison of ridaforolimus-eluting and zotarolimus-eluting coronary stents: 5-Year outcomes from the BIONICS and NIREUS trials

Session: Decision-making for revascularisation of multivessel disease

Topic: Devices

Speaker: Doctor L. Zornitzki (Tel Aviv, IL)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Lior Zornitzki

Tel Aviv Sourasky Medical Center, Tel Aviv (Israel)

0 follower

5 more presentations in this session

Clinical outcome based on functional complete revascularization in patients with three-vessel coronary artery disease: The FAME 3 Trial

Speaker: Doctor H. Otsuki (Stanford, US)

Performance and safety of complex percutaneous coronary intervention in centres without on-site cardiac surgery: a multi-centre australian registry study.

Speaker: Doctor N. Dayawansa (Melbourne, AU)

Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with left main coronary artery disease and chronic kidney disease: a systematic review and meta-analysis

Speaker: Doctor I. Gialamas (Athens, GR)

Impact of preoperative quantitative flow ratio on long term coronary artery bypass grafts patency

Speaker: Doctor J. Andreka (Graz, AT)

Ten-year comparative long-term outcomes of PCI versus CABG in multi-vessel coronary artery disease

Speaker: Professor S. Sung (Taipei, TW)

Access the full session

Decision-making for revascularisation of multivessel disease

Speakers: Doctor L. Zornitzki, Doctor H. Otsuki, Doctor N. Dayawansa, Doctor I. Gialamas, Doctor J. Andreka...

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources